Arkea Bio is based in Boston. It has raised $40M in total funding. Latest round: Series A.
Arkea Bio is based in Boston. Arkea Bio has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Arkea Bio runs through 2025; nothing later has been disclosed. Investors on record include Breakthrough Energy Ventures, AgriZeroNZ, The Grantham Foundation, Rabo Ventures, Synthesis Capital, Overview Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Every Arkea Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026